![(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%](https://img.nicebiochem.com/20250502/89f20c8981610e19156414693f4e35e9bbcfb53340c3e8864505e2df67fc248b.png)
(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%
-
（4R，4''R，5S，5''S）-2,2''-环亚丙基二[4,5-二氢-4,5-二苯基恶唑] (4R,4''R,5S,5''S)-2,2''-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole]
S56700-250mg | 250mg
-
（4R，4''R，5S，5''S）-2,2''-环亚丙基二[4,5-二氢-4,5-二苯基恶唑] (4R,4''R,5S,5''S)-2,2''-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole]
S56700-1g | 1g
-
(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%
ZMR-07-1085 | 100mg
-
(4R,4'R,5S,5'S)-2,2'-环己叉二[4,5-二氢-4,5-二苯基噁唑 (4R,4'R,5S,5'S)-2,2'-(Cyclohexane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
V82336-1g | 1g
-
(4R,4'R,5S,5'S)-2,2'-环己叉二[4,5-二氢-4,5-二苯基噁唑 (4R,4'R,5S,5'S)-2,2'-(Cyclohexane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
V82336-250mg | 250mg
-
(4R,4'R,5S,5'S)-2,2'-(戊烷-3,3-二基)双(4,5-二苯基-4,5-二氢恶唑) (4R,4'R,5S,5'S)-2,2'-(Pentane-3,3-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
S56793-1g | 1g
-
(4R,4'R,5S,5'S)-2,2'-环丁亚基双[4,5-双-4,5-二苯基噁唑 (4R,4'R,5S,5'S)-2,2'-(Cyclobutane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
V82967-250mg | 250mg
中文名称：(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％
英文名称：(4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%
其他规格：25mg；分子式：C34H30N2O2；分子量：498.6；储存条件：Store at 2-8℃。
您正在浏览的产品：(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％
手机版：(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。
2. 色谱柱平衡：流动相平衡至少30分钟，柱温25-40℃；
3. 进样量：5-20 μL，流速1.0 mL/min。
2. 需定期验证色谱柱塔板数和分离度（R≥1.5）；
3. 标准物质需避光保存（-20℃），开封后有效期6个月。
以上信息仅供参考，请以相应标准的原文为准！